Advisory: Alert incorrectly tagged to Quince Therapeutics withdrawn
An alert on consumer technology platform Quince announcing a $500 million financing round was inadvertently tagged to Quince Therapeutics QNCX.O, an unrelated company, and has been withdrawn. For the correct set of alerts, click nFWN3ZZ04K STORY_NUMBER: nFWN3ZZ09M STORY_DATE: 11/03/2026 STORY_TIME: 10:00 AM GMT ((Bangalore.newsroom@thomsonreuters.com))
Recent news on IRulya Therapeutics
See all newsBrief: Quince Therapeutics - Changes Name To Irulya Therapeutics
Brief: Quince Therapeutics - Appoints Brigette Roberts As CEO Effective October 8, 2026
Quince Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Brief: Quince Therapeutics Reports Second Quarter 2026 Financial Results And Corporate Update
Quince Therapeutics Q2 net loss widens on acquisition charges